The mechanisms underlying this glioma-specific function of lncGRS-1 remain to be discovered, but upon lncGRS-1 knockdown, we did observe activation of the p53 signaling pathway leading to upregulation of p53 effectors such as p21, correlating with a decrease in cell cycle progression. The gene discussed is TP53; the disease is central nervous system cancer.